Kris Westelinck appointed president of Pfizer Belgium
April 5, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, researcha and development, sales and marketing
Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …
ABPI appoints new head
April 5, 2011Manufacturing and Production, Research and Development, Sales and Marketing ABPI, appointment
The ABPI has appointed former Prudential communications director Stephen Whitehead as its new head. He joins the UK pharma industry …
Digital Pharma: UK gets social media guidance
April 5, 2011Medical Communications Code of Practice, Digital Pharma blog, PMCPA, digital marketing
The UK’s Code of Practice regulator has issued guidance on social media and other digital communications tools. It is the …
J&J reorganises McNeil as recalls keep coming
April 5, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole
Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …
Pfizer sells drug delivery unit Capsugel for $2.38bn
April 5, 2011Manufacturing and Production Capsugel, Kohlberg Kravis Roberts & Co, Pfizer, pharmaceutical capsules
Pfizer has agreed to sell its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. for $2.38 billion …
Government urged to slow pace of NHS reforms
April 4, 2011Sales and Marketing GP consortia, Liberating the NHS, NHS reform
The Government should slow down its health reform programme to allow GPs to grow into their new role, the think …
Interphex: manufacturing product showcase
April 4, 2011Manufacturing and Production Interphex, PTI Inspection Systems, Pall Corp
This year’s Interphex exhibition in New York featured the usual crop of new product launches from processing and packaging equipment …
China’s new GMP rules will lead to industry consolidation
April 4, 2011Manufacturing and Production China, GMP
China’s new rules on Good Manufacturing Practice is likely to drive consolidation among the country’s 5,000-plus pharmaceutical companies, according to …
New BMS drug trumps peg-interferon alpha
April 4, 2011Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa
Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …
Doubts cast on new Cancer Drugs Fund
April 1, 2011Cancer Drugs Fund, value-based pricing
There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …
Angela Pasma to lead Chiltern’s new Netherlands office
April 1, 2011Research and Development appointment, chiltern, research and development
Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …
Amgen’s novel lung cancer drug disappoints in phase III
April 1, 2011Research and Development Amgen, Millennium, NSCLC, Takeda, motesanib, non-small cell lung cancer
Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …
GSK details $28.5m of research payments to US institutions
April 1, 2011Research and Development GSK, payments
GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …
TcL Pharma appoints French pharma veterans
April 1, 2011Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment
TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …
NHS reforms caught in a ‘reality gap’ as dissent grows
March 31, 2011Andrew Lansley, Liberating the NHS, NHS, NHS reform
The proposed NHS reforms are in danger of failing because of a ‘reality gap’ between the government’s ambitions for change …
AstraZeneca pays $1.1bn to resolve tax affairs
March 31, 2011Sales and Marketing AstraZeneca, tax
AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …
Valeant makes $5.7 billion hostile bid for Cephalon
March 31, 2011Research and Development, Sales and Marketing Cephalon, Valeant
Valeant has made a hostile bid for Cephalon, but analysts believe its offer is too low for the deal to …
Roche appoints Janet Hammond to translational medicine role
March 31, 2011Research and Development appointment, research and development
Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …
AZ’s Dr Yunxia Bi joins ISP
March 30, 2011Manufacturing and Production appointment, manufacturing and production
ISP Pharmaceuticals has appointed Dr Yunxia (Vivian) Bi as technical director of its solubility initiative. It is a newly-created position …
Merck re-submits Erbitux to the EMA for lung cancer
March 30, 2011Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer
Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
